nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ALB—Estropipate—osteoporosis	0.137	0.169	CbGbCtD
Acenocoumarol—CYP1A2—Estropipate—osteoporosis	0.0819	0.101	CbGbCtD
Acenocoumarol—CYP2C9—Estropipate—osteoporosis	0.0738	0.0911	CbGbCtD
Acenocoumarol—ALB—Estradiol—osteoporosis	0.0569	0.0702	CbGbCtD
Acenocoumarol—CYP2C19—Cholecalciferol—osteoporosis	0.0457	0.0564	CbGbCtD
Acenocoumarol—CYP3A4—Estropipate—osteoporosis	0.0429	0.053	CbGbCtD
Acenocoumarol—CYP3A4—Calcitriol—osteoporosis	0.0429	0.053	CbGbCtD
Acenocoumarol—CYP1A2—Conjugated Estrogens—osteoporosis	0.0387	0.0478	CbGbCtD
Acenocoumarol—CYP2C9—Cholecalciferol—osteoporosis	0.038	0.0469	CbGbCtD
Acenocoumarol—CYP2C19—Estradiol—osteoporosis	0.0369	0.0455	CbGbCtD
Acenocoumarol—CYP3A4—Ergocalciferol—osteoporosis	0.0343	0.0423	CbGbCtD
Acenocoumarol—CYP1A2—Estradiol—osteoporosis	0.034	0.042	CbGbCtD
Acenocoumarol—CYP2C9—Estradiol—osteoporosis	0.0306	0.0378	CbGbCtD
Acenocoumarol—CYP3A4—Raloxifene—osteoporosis	0.0286	0.0353	CbGbCtD
Acenocoumarol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0277	0.0341	CbGbCtD
Acenocoumarol—CYP3A4—Cholecalciferol—osteoporosis	0.0221	0.0273	CbGbCtD
Acenocoumarol—CYP3A4—Conjugated Estrogens—osteoporosis	0.0203	0.0251	CbGbCtD
Acenocoumarol—CYP3A4—Estradiol—osteoporosis	0.0178	0.022	CbGbCtD
Acenocoumarol—Appetite absent—Ibandronate—osteoporosis	0.00623	0.0348	CcSEcCtD
Acenocoumarol—Metrorrhagia—Estropipate—osteoporosis	0.00453	0.0252	CcSEcCtD
Acenocoumarol—Metrorrhagia—Ethinyl Estradiol—osteoporosis	0.00367	0.0205	CcSEcCtD
Acenocoumarol—Menorrhagia—Ethinyl Estradiol—osteoporosis	0.00354	0.0197	CcSEcCtD
Acenocoumarol—Ulcer—Alendronate—osteoporosis	0.00337	0.0188	CcSEcCtD
Acenocoumarol—Ulcer—Ibandronate—osteoporosis	0.00328	0.0183	CcSEcCtD
Acenocoumarol—Coagulopathy—Pamidronate—osteoporosis	0.00312	0.0174	CcSEcCtD
Acenocoumarol—Melaena—Alendronate—osteoporosis	0.00311	0.0173	CcSEcCtD
Acenocoumarol—Haematuria—Calcium Acetate—osteoporosis	0.00304	0.0169	CcSEcCtD
Acenocoumarol—Metrorrhagia—Conjugated Estrogens—osteoporosis	0.00299	0.0167	CcSEcCtD
Acenocoumarol—Neoplasm—Estropipate—osteoporosis	0.00292	0.0163	CcSEcCtD
Acenocoumarol—Coagulopathy—Zoledronate—osteoporosis	0.00285	0.0159	CcSEcCtD
Acenocoumarol—Coagulopathy—Conjugated Estrogens—osteoporosis	0.00275	0.0153	CcSEcCtD
Acenocoumarol—Ulcer—Risedronate—osteoporosis	0.0027	0.0151	CcSEcCtD
Acenocoumarol—Metrorrhagia—Estradiol—osteoporosis	0.0024	0.0133	CcSEcCtD
Acenocoumarol—Neoplasm—Ethinyl Estradiol—osteoporosis	0.00237	0.0132	CcSEcCtD
Acenocoumarol—Neoplasm—Risedronate—osteoporosis	0.00231	0.0129	CcSEcCtD
Acenocoumarol—Menorrhagia—Estradiol—osteoporosis	0.00231	0.0129	CcSEcCtD
Acenocoumarol—Ulcer—Conjugated Estrogens—osteoporosis	0.00226	0.0126	CcSEcCtD
Acenocoumarol—Coagulopathy—Estradiol—osteoporosis	0.0022	0.0122	CcSEcCtD
Acenocoumarol—Neoplasm—Zoledronate—osteoporosis	0.00201	0.0112	CcSEcCtD
Acenocoumarol—Neoplasm—Conjugated Estrogens—osteoporosis	0.00193	0.0108	CcSEcCtD
Acenocoumarol—Ulcer—Estradiol—osteoporosis	0.00181	0.0101	CcSEcCtD
Acenocoumarol—Decreased appetite—Calcium Acetate—osteoporosis	0.00177	0.00985	CcSEcCtD
Acenocoumarol—Alopecia—Etidronic acid—osteoporosis	0.00166	0.00925	CcSEcCtD
Acenocoumarol—Skin exfoliation—Estradiol—osteoporosis	0.00163	0.0091	CcSEcCtD
Acenocoumarol—Haemoglobin—Alendronate—osteoporosis	0.00161	0.00896	CcSEcCtD
Acenocoumarol—Haemorrhage—Alendronate—osteoporosis	0.0016	0.00892	CcSEcCtD
Acenocoumarol—Haemoglobin—Ibandronate—osteoporosis	0.00157	0.00873	CcSEcCtD
Acenocoumarol—Decreased appetite—Ergocalciferol—osteoporosis	0.00156	0.0087	CcSEcCtD
Acenocoumarol—Haemorrhage—Ibandronate—osteoporosis	0.00156	0.00868	CcSEcCtD
Acenocoumarol—Neoplasm—Estradiol—osteoporosis	0.00155	0.00862	CcSEcCtD
Acenocoumarol—Haemoglobin—Calcitriol—osteoporosis	0.00153	0.00854	CcSEcCtD
Acenocoumarol—Haemorrhage—Calcitriol—osteoporosis	0.00153	0.0085	CcSEcCtD
Acenocoumarol—Hypersensitivity—Calcium Acetate—osteoporosis	0.0015	0.00835	CcSEcCtD
Acenocoumarol—Alopecia—Estropipate—osteoporosis	0.00144	0.008	CcSEcCtD
Acenocoumarol—Alopecia—Alendronate—osteoporosis	0.00141	0.00788	CcSEcCtD
Acenocoumarol—Diarrhoea—Calcium Acetate—osteoporosis	0.00139	0.00775	CcSEcCtD
Acenocoumarol—Alopecia—Ibandronate—osteoporosis	0.00138	0.00767	CcSEcCtD
Acenocoumarol—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00132	0.00738	CcSEcCtD
Acenocoumarol—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00132	0.00734	CcSEcCtD
Acenocoumarol—Haematuria—Pamidronate—osteoporosis	0.0013	0.00722	CcSEcCtD
Acenocoumarol—Vomiting—Calcium Acetate—osteoporosis	0.00129	0.0072	CcSEcCtD
Acenocoumarol—Haemoglobin—Risedronate—osteoporosis	0.00129	0.00719	CcSEcCtD
Acenocoumarol—Haemorrhage—Risedronate—osteoporosis	0.00128	0.00716	CcSEcCtD
Acenocoumarol—Haemoglobin—Pamidronate—osteoporosis	0.00123	0.00684	CcSEcCtD
Acenocoumarol—Haemorrhage—Pamidronate—osteoporosis	0.00122	0.0068	CcSEcCtD
Acenocoumarol—Nausea—Calcium Acetate—osteoporosis	0.00121	0.00673	CcSEcCtD
Acenocoumarol—Haematuria—Zoledronate—osteoporosis	0.00118	0.0066	CcSEcCtD
Acenocoumarol—Alopecia—Ethinyl Estradiol—osteoporosis	0.00116	0.00649	CcSEcCtD
Acenocoumarol—Alopecia—Pamidronate—osteoporosis	0.00108	0.00601	CcSEcCtD
Acenocoumarol—Nausea—Ergocalciferol—osteoporosis	0.00107	0.00594	CcSEcCtD
Acenocoumarol—Urticaria—Etidronic acid—osteoporosis	0.00106	0.00591	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Estropipate—osteoporosis	0.000996	0.00555	CcSEcCtD
Acenocoumarol—Alopecia—Zoledronate—osteoporosis	0.000985	0.00549	CcSEcCtD
Acenocoumarol—Hypersensitivity—Etidronic acid—osteoporosis	0.000983	0.00548	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000965	0.00538	CcSEcCtD
Acenocoumarol—Decreased appetite—Ibandronate—osteoporosis	0.000962	0.00536	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000956	0.00533	CcSEcCtD
Acenocoumarol—Alopecia—Conjugated Estrogens—osteoporosis	0.000949	0.00529	CcSEcCtD
Acenocoumarol—Decreased appetite—Calcitriol—osteoporosis	0.000942	0.00525	CcSEcCtD
Acenocoumarol—Urticaria—Estropipate—osteoporosis	0.000917	0.00511	CcSEcCtD
Acenocoumarol—Diarrhoea—Etidronic acid—osteoporosis	0.000913	0.00509	CcSEcCtD
Acenocoumarol—Haematuria—Estradiol—osteoporosis	0.000912	0.00509	CcSEcCtD
Acenocoumarol—Body temperature increased—Estropipate—osteoporosis	0.000912	0.00509	CcSEcCtD
Acenocoumarol—Urticaria—Alendronate—osteoporosis	0.000903	0.00503	CcSEcCtD
Acenocoumarol—Body temperature increased—Alendronate—osteoporosis	0.000899	0.00501	CcSEcCtD
Acenocoumarol—Body temperature increased—Raloxifene—osteoporosis	0.000884	0.00493	CcSEcCtD
Acenocoumarol—Urticaria—Ibandronate—osteoporosis	0.000879	0.0049	CcSEcCtD
Acenocoumarol—Body temperature increased—Ibandronate—osteoporosis	0.000875	0.00488	CcSEcCtD
Acenocoumarol—Haemoglobin—Estradiol—osteoporosis	0.000863	0.00481	CcSEcCtD
Acenocoumarol—Urticaria—Calcitriol—osteoporosis	0.000861	0.0048	CcSEcCtD
Acenocoumarol—Haemorrhage—Estradiol—osteoporosis	0.000859	0.00479	CcSEcCtD
Acenocoumarol—Body temperature increased—Calcitriol—osteoporosis	0.000856	0.00477	CcSEcCtD
Acenocoumarol—Hypersensitivity—Estropipate—osteoporosis	0.00085	0.00474	CcSEcCtD
Acenocoumarol—Vomiting—Etidronic acid—osteoporosis	0.000848	0.00473	CcSEcCtD
Acenocoumarol—Dermatitis—Etidronic acid—osteoporosis	0.00084	0.00468	CcSEcCtD
Acenocoumarol—Hypersensitivity—Alendronate—osteoporosis	0.000838	0.00467	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ibandronate—osteoporosis	0.000815	0.00454	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000808	0.0045	CcSEcCtD
Acenocoumarol—Hypersensitivity—Calcitriol—osteoporosis	0.000798	0.00445	CcSEcCtD
Acenocoumarol—Nausea—Etidronic acid—osteoporosis	0.000792	0.00442	CcSEcCtD
Acenocoumarol—Diarrhoea—Estropipate—osteoporosis	0.00079	0.0044	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000787	0.00439	CcSEcCtD
Acenocoumarol—Diarrhoea—Alendronate—osteoporosis	0.000778	0.00434	CcSEcCtD
Acenocoumarol—Diarrhoea—Raloxifene—osteoporosis	0.000765	0.00426	CcSEcCtD
Acenocoumarol—Alopecia—Estradiol—osteoporosis	0.000759	0.00423	CcSEcCtD
Acenocoumarol—Diarrhoea—Ibandronate—osteoporosis	0.000757	0.00422	CcSEcCtD
Acenocoumarol—Decreased appetite—Pamidronate—osteoporosis	0.000754	0.0042	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000749	0.00417	CcSEcCtD
Acenocoumarol—Urticaria—Ethinyl Estradiol—osteoporosis	0.000743	0.00414	CcSEcCtD
Acenocoumarol—Diarrhoea—Calcitriol—osteoporosis	0.000741	0.00413	CcSEcCtD
Acenocoumarol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00074	0.00412	CcSEcCtD
Acenocoumarol—Vomiting—Estropipate—osteoporosis	0.000734	0.00409	CcSEcCtD
Acenocoumarol—Dermatitis—Estropipate—osteoporosis	0.000727	0.00405	CcSEcCtD
Acenocoumarol—Urticaria—Risedronate—osteoporosis	0.000725	0.00404	CcSEcCtD
Acenocoumarol—Vomiting—Alendronate—osteoporosis	0.000723	0.00403	CcSEcCtD
Acenocoumarol—Body temperature increased—Risedronate—osteoporosis	0.000721	0.00402	CcSEcCtD
Acenocoumarol—Dermatitis—Alendronate—osteoporosis	0.000716	0.00399	CcSEcCtD
Acenocoumarol—Vomiting—Raloxifene—osteoporosis	0.000711	0.00396	CcSEcCtD
Acenocoumarol—Dermatitis—Raloxifene—osteoporosis	0.000704	0.00393	CcSEcCtD
Acenocoumarol—Vomiting—Ibandronate—osteoporosis	0.000704	0.00392	CcSEcCtD
Acenocoumarol—Dermatitis—Ibandronate—osteoporosis	0.000697	0.00389	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000689	0.00384	CcSEcCtD
Acenocoumarol—Vomiting—Calcitriol—osteoporosis	0.000689	0.00384	CcSEcCtD
Acenocoumarol—Decreased appetite—Zoledronate—osteoporosis	0.000689	0.00384	CcSEcCtD
Acenocoumarol—Nausea—Estropipate—osteoporosis	0.000686	0.00382	CcSEcCtD
Acenocoumarol—Body temperature increased—Pamidronate—osteoporosis	0.000685	0.00382	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000684	0.00381	CcSEcCtD
Acenocoumarol—Dermatitis—Calcitriol—osteoporosis	0.000683	0.0038	CcSEcCtD
Acenocoumarol—Nausea—Alendronate—osteoporosis	0.000675	0.00376	CcSEcCtD
Acenocoumarol—Hypersensitivity—Risedronate—osteoporosis	0.000672	0.00375	CcSEcCtD
Acenocoumarol—Nausea—Raloxifene—osteoporosis	0.000664	0.0037	CcSEcCtD
Acenocoumarol—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000663	0.0037	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000658	0.00367	CcSEcCtD
Acenocoumarol—Nausea—Ibandronate—osteoporosis	0.000657	0.00366	CcSEcCtD
Acenocoumarol—Nausea—Calcitriol—osteoporosis	0.000644	0.00359	CcSEcCtD
Acenocoumarol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00064	0.00357	CcSEcCtD
Acenocoumarol—Hypersensitivity—Pamidronate—osteoporosis	0.000639	0.00356	CcSEcCtD
Acenocoumarol—Urticaria—Zoledronate—osteoporosis	0.000629	0.00351	CcSEcCtD
Acenocoumarol—Body temperature increased—Zoledronate—osteoporosis	0.000626	0.00349	CcSEcCtD
Acenocoumarol—Diarrhoea—Risedronate—osteoporosis	0.000624	0.00348	CcSEcCtD
Acenocoumarol—Urticaria—Conjugated Estrogens—osteoporosis	0.000606	0.00338	CcSEcCtD
Acenocoumarol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000603	0.00336	CcSEcCtD
Acenocoumarol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000595	0.00332	CcSEcCtD
Acenocoumarol—Diarrhoea—Pamidronate—osteoporosis	0.000593	0.00331	CcSEcCtD
Acenocoumarol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000589	0.00328	CcSEcCtD
Acenocoumarol—Hypersensitivity—Zoledronate—osteoporosis	0.000584	0.00325	CcSEcCtD
Acenocoumarol—Vomiting—Risedronate—osteoporosis	0.00058	0.00323	CcSEcCtD
Acenocoumarol—Dermatitis—Risedronate—osteoporosis	0.000575	0.0032	CcSEcCtD
Acenocoumarol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000562	0.00313	CcSEcCtD
Acenocoumarol—Nausea—Ethinyl Estradiol—osteoporosis	0.000556	0.0031	CcSEcCtD
Acenocoumarol—Vomiting—Pamidronate—osteoporosis	0.000551	0.00307	CcSEcCtD
Acenocoumarol—Dermatitis—Pamidronate—osteoporosis	0.000546	0.00304	CcSEcCtD
Acenocoumarol—Diarrhoea—Zoledronate—osteoporosis	0.000542	0.00302	CcSEcCtD
Acenocoumarol—Nausea—Risedronate—osteoporosis	0.000542	0.00302	CcSEcCtD
Acenocoumarol—Decreased appetite—Estradiol—osteoporosis	0.000531	0.00296	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000527	0.00294	CcSEcCtD
Acenocoumarol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000522	0.00291	CcSEcCtD
Acenocoumarol—Nausea—Pamidronate—osteoporosis	0.000515	0.00287	CcSEcCtD
Acenocoumarol—Vomiting—Zoledronate—osteoporosis	0.000504	0.00281	CcSEcCtD
Acenocoumarol—Dermatitis—Zoledronate—osteoporosis	0.000499	0.00278	CcSEcCtD
Acenocoumarol—Vomiting—Conjugated Estrogens—osteoporosis	0.000485	0.0027	CcSEcCtD
Acenocoumarol—Urticaria—Estradiol—osteoporosis	0.000485	0.0027	CcSEcCtD
Acenocoumarol—Body temperature increased—Estradiol—osteoporosis	0.000483	0.00269	CcSEcCtD
Acenocoumarol—Dermatitis—Conjugated Estrogens—osteoporosis	0.00048	0.00268	CcSEcCtD
Acenocoumarol—Nausea—Zoledronate—osteoporosis	0.00047	0.00262	CcSEcCtD
Acenocoumarol—Nausea—Conjugated Estrogens—osteoporosis	0.000453	0.00252	CcSEcCtD
Acenocoumarol—Hypersensitivity—Estradiol—osteoporosis	0.00045	0.00251	CcSEcCtD
Acenocoumarol—Diarrhoea—Estradiol—osteoporosis	0.000418	0.00233	CcSEcCtD
Acenocoumarol—Vomiting—Estradiol—osteoporosis	0.000388	0.00216	CcSEcCtD
Acenocoumarol—Dermatitis—Estradiol—osteoporosis	0.000384	0.00214	CcSEcCtD
Acenocoumarol—Nausea—Estradiol—osteoporosis	0.000363	0.00202	CcSEcCtD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	5.6e-05	0.00542	CbGpPWpGaD
Acenocoumarol—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	5.56e-05	0.00538	CbGpPWpGaD
Acenocoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.47e-05	0.00529	CbGpPWpGaD
Acenocoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.39e-05	0.00522	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—SOD2—osteoporosis	5.28e-05	0.00511	CbGpPWpGaD
Acenocoumarol—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	5.15e-05	0.00498	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	5.13e-05	0.00496	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—GPX1—osteoporosis	5.04e-05	0.00488	CbGpPWpGaD
Acenocoumarol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4.96e-05	0.0048	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	4.91e-05	0.00476	CbGpPWpGaD
Acenocoumarol—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.86e-05	0.0047	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	4.85e-05	0.00469	CbGpPWpGaD
Acenocoumarol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4.67e-05	0.00452	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—MTHFR—osteoporosis	4.65e-05	0.0045	CbGpPWpGaD
Acenocoumarol—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	4.61e-05	0.00446	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—WDR1—osteoporosis	4.6e-05	0.00445	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	4.48e-05	0.00434	CbGpPWpGaD
Acenocoumarol—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	4.46e-05	0.00431	CbGpPWpGaD
Acenocoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.43e-05	0.00429	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	4.42e-05	0.00428	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	4.42e-05	0.00427	CbGpPWpGaD
Acenocoumarol—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	4.4e-05	0.00426	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	4.36e-05	0.00422	CbGpPWpGaD
Acenocoumarol—VKORC1—Metabolism of proteins—LEP—osteoporosis	4.31e-05	0.00417	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	4.2e-05	0.00406	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	4e-05	0.00387	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	3.86e-05	0.00373	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	3.83e-05	0.00371	CbGpPWpGaD
Acenocoumarol—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.79e-05	0.00366	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	3.78e-05	0.00365	CbGpPWpGaD
Acenocoumarol—VKORC1—Metabolism of proteins—POMC—osteoporosis	3.7e-05	0.00358	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	3.69e-05	0.00357	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.66e-05	0.00354	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	3.64e-05	0.00352	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—CAP1—osteoporosis	3.64e-05	0.00352	CbGpPWpGaD
Acenocoumarol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.61e-05	0.00349	CbGpPWpGaD
Acenocoumarol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.6e-05	0.00349	CbGpPWpGaD
Acenocoumarol—VKORC1—Metabolism of proteins—IGF1—osteoporosis	3.56e-05	0.00345	CbGpPWpGaD
Acenocoumarol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.56e-05	0.00344	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.47e-05	0.00336	CbGpPWpGaD
Acenocoumarol—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	3.39e-05	0.00328	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	3.3e-05	0.0032	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.29e-05	0.00318	CbGpPWpGaD
Acenocoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.29e-05	0.00318	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.11e-05	0.00301	CbGpPWpGaD
Acenocoumarol—ALB—Platelet degranulation—IGF1—osteoporosis	3.07e-05	0.00297	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	3e-05	0.00291	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3e-05	0.0029	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.96e-05	0.00286	CbGpPWpGaD
Acenocoumarol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.92e-05	0.00283	CbGpPWpGaD
Acenocoumarol—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	2.92e-05	0.00283	CbGpPWpGaD
Acenocoumarol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.92e-05	0.00283	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.91e-05	0.00282	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MGLL—osteoporosis	2.89e-05	0.00279	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.84e-05	0.00275	CbGpPWpGaD
Acenocoumarol—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.81e-05	0.00272	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—IL1B—osteoporosis	2.76e-05	0.00267	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.7e-05	0.00261	CbGpPWpGaD
Acenocoumarol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.66e-05	0.00258	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PLEK—osteoporosis	2.64e-05	0.00256	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—ANXA2—osteoporosis	2.64e-05	0.00256	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.63e-05	0.00254	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	2.58e-05	0.0025	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	2.58e-05	0.00249	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.56e-05	0.00248	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	2.55e-05	0.00246	CbGpPWpGaD
Acenocoumarol—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	2.46e-05	0.00238	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.43e-05	0.00235	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.42e-05	0.00234	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.36e-05	0.00228	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	2.35e-05	0.00228	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	2.32e-05	0.00225	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.29e-05	0.00221	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TLN1—osteoporosis	2.28e-05	0.0022	CbGpPWpGaD
Acenocoumarol—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.28e-05	0.0022	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VCL—osteoporosis	2.25e-05	0.00217	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.21e-05	0.00214	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	2.19e-05	0.00212	CbGpPWpGaD
Acenocoumarol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.17e-05	0.0021	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.15e-05	0.00208	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.1e-05	0.00203	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.01e-05	0.00195	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.01e-05	0.00194	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—TNF—osteoporosis	2e-05	0.00194	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2e-05	0.00194	CbGpPWpGaD
Acenocoumarol—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	1.99e-05	0.00192	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	1.98e-05	0.00192	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.89e-05	0.00183	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.89e-05	0.00183	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—RAP1A—osteoporosis	1.88e-05	0.00182	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.87e-05	0.00181	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.87e-05	0.00181	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.84e-05	0.00178	CbGpPWpGaD
Acenocoumarol—ALB—Platelet degranulation—TGFB1—osteoporosis	1.84e-05	0.00178	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.79e-05	0.00173	CbGpPWpGaD
Acenocoumarol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.76e-05	0.0017	CbGpPWpGaD
Acenocoumarol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	1.75e-05	0.00169	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.72e-05	0.00167	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—FGA—osteoporosis	1.7e-05	0.00165	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—FDPS—osteoporosis	1.63e-05	0.00158	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PKM—osteoporosis	1.63e-05	0.00158	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—IL6—osteoporosis	1.62e-05	0.00156	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.6e-05	0.00155	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—TNF—osteoporosis	1.59e-05	0.00154	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.55e-05	0.0015	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—POMC—osteoporosis	1.55e-05	0.0015	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—FGB—osteoporosis	1.55e-05	0.0015	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PGLS—osteoporosis	1.55e-05	0.0015	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPD2—osteoporosis	1.55e-05	0.0015	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.53e-05	0.00148	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.47e-05	0.00142	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PKM—osteoporosis	1.46e-05	0.00142	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—FDPS—osteoporosis	1.46e-05	0.00142	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.46e-05	0.00142	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—POMC—osteoporosis	1.41e-05	0.00137	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PNP—osteoporosis	1.41e-05	0.00137	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ATIC—osteoporosis	1.41e-05	0.00137	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPD2—osteoporosis	1.39e-05	0.00134	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PGLS—osteoporosis	1.39e-05	0.00134	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.36e-05	0.00132	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—FDPS—osteoporosis	1.33e-05	0.00129	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PKM—osteoporosis	1.33e-05	0.00129	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.28e-05	0.00124	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ATIC—osteoporosis	1.27e-05	0.00123	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PNP—osteoporosis	1.27e-05	0.00123	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PGLS—osteoporosis	1.26e-05	0.00122	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPD2—osteoporosis	1.26e-05	0.00122	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.25e-05	0.00121	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—POMC—osteoporosis	1.21e-05	0.00117	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—OXCT1—osteoporosis	1.2e-05	0.00116	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CA2—osteoporosis	1.2e-05	0.00116	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MGLL—osteoporosis	1.17e-05	0.00113	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PNP—osteoporosis	1.16e-05	0.00112	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ATIC—osteoporosis	1.16e-05	0.00112	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PKM—osteoporosis	1.14e-05	0.0011	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—FDPS—osteoporosis	1.14e-05	0.0011	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.1e-05	0.00107	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PGLS—osteoporosis	1.08e-05	0.00105	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPD2—osteoporosis	1.08e-05	0.00105	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—OXCT1—osteoporosis	1.08e-05	0.00104	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CA2—osteoporosis	1.08e-05	0.00104	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MGLL—osteoporosis	1.05e-05	0.00102	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—IDH2—osteoporosis	9.96e-06	0.000964	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.91e-06	0.000959	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PNP—osteoporosis	9.89e-06	0.000957	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ATIC—osteoporosis	9.89e-06	0.000957	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CA2—osteoporosis	9.84e-06	0.000952	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—OXCT1—osteoporosis	9.84e-06	0.000952	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MGLL—osteoporosis	9.59e-06	0.000928	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP27A1—osteoporosis	9.36e-06	0.000906	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—POMC—osteoporosis	9.33e-06	0.000903	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ACP5—osteoporosis	9.11e-06	0.000881	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.04e-06	0.000875	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.99e-06	0.00087	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—IDH2—osteoporosis	8.94e-06	0.000865	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—FDPS—osteoporosis	8.8e-06	0.000851	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PKM—osteoporosis	8.8e-06	0.000851	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.58e-06	0.00083	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TPI1—osteoporosis	8.47e-06	0.000819	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CA2—osteoporosis	8.41e-06	0.000813	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—OXCT1—osteoporosis	8.41e-06	0.000813	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP27A1—osteoporosis	8.4e-06	0.000813	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PGLS—osteoporosis	8.34e-06	0.000807	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPD2—osteoporosis	8.34e-06	0.000807	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MGLL—osteoporosis	8.19e-06	0.000793	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ACP5—osteoporosis	8.18e-06	0.000791	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.16e-06	0.000789	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—IDH2—osteoporosis	8.15e-06	0.000789	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.07e-06	0.000781	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—P4HB—osteoporosis	7.96e-06	0.00077	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GAPDH—osteoporosis	7.81e-06	0.000756	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.72e-06	0.000747	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP27A1—osteoporosis	7.66e-06	0.000742	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ATIC—osteoporosis	7.63e-06	0.000738	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PNP—osteoporosis	7.63e-06	0.000738	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—RAP1A—osteoporosis	7.61e-06	0.000736	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TPI1—osteoporosis	7.6e-06	0.000735	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ACP5—osteoporosis	7.45e-06	0.000721	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.36e-06	0.000712	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—P4HB—osteoporosis	7.15e-06	0.000691	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GAPDH—osteoporosis	7.01e-06	0.000679	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IGF1—osteoporosis	7.01e-06	0.000679	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—IDH2—osteoporosis	6.97e-06	0.000674	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TPI1—osteoporosis	6.93e-06	0.000671	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—RAP1A—osteoporosis	6.83e-06	0.000661	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.64e-06	0.000642	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP27A1—osteoporosis	6.55e-06	0.000634	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—P4HB—osteoporosis	6.52e-06	0.000631	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—OXCT1—osteoporosis	6.49e-06	0.000628	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CA2—osteoporosis	6.49e-06	0.000628	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GAPDH—osteoporosis	6.4e-06	0.000619	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ACP5—osteoporosis	6.37e-06	0.000616	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MGLL—osteoporosis	6.32e-06	0.000612	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.29e-06	0.000609	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—RAP1A—osteoporosis	6.23e-06	0.000603	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ENO1—osteoporosis	6.15e-06	0.000595	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PSMA5—osteoporosis	6.06e-06	0.000587	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PSMA2—osteoporosis	6.06e-06	0.000587	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.96e-06	0.000576	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TPI1—osteoporosis	5.92e-06	0.000573	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—P4HB—osteoporosis	5.57e-06	0.000539	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ENO1—osteoporosis	5.52e-06	0.000534	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GAPDH—osteoporosis	5.47e-06	0.000529	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PSMA2—osteoporosis	5.44e-06	0.000527	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PSMA5—osteoporosis	5.44e-06	0.000527	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.43e-06	0.000526	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—IDH2—osteoporosis	5.38e-06	0.00052	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—RAP1A—osteoporosis	5.32e-06	0.000515	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.05e-06	0.000489	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ENO1—osteoporosis	5.04e-06	0.000487	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PSMA2—osteoporosis	4.96e-06	0.00048	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PSMA5—osteoporosis	4.96e-06	0.00048	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP19A1—osteoporosis	4.92e-06	0.000476	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ACP5—osteoporosis	4.92e-06	0.000476	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.64e-06	0.000449	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TPI1—osteoporosis	4.57e-06	0.000442	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.41e-06	0.000427	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ENO1—osteoporosis	4.3e-06	0.000416	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—P4HB—osteoporosis	4.3e-06	0.000416	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PSMA5—osteoporosis	4.24e-06	0.00041	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PSMA2—osteoporosis	4.24e-06	0.00041	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GAPDH—osteoporosis	4.22e-06	0.000408	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TGFB1—osteoporosis	4.2e-06	0.000407	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—RAP1A—osteoporosis	4.11e-06	0.000398	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.03e-06	0.00039	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ADCY5—osteoporosis	4.02e-06	0.000389	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPX1—osteoporosis	4e-06	0.000387	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MTHFR—osteoporosis	3.7e-06	0.000358	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ADCY5—osteoporosis	3.61e-06	0.000349	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPX1—osteoporosis	3.59e-06	0.000348	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP19A1—osteoporosis	3.44e-06	0.000333	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ENO1—osteoporosis	3.32e-06	0.000321	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MTHFR—osteoporosis	3.32e-06	0.000321	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ADCY5—osteoporosis	3.29e-06	0.000318	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPX1—osteoporosis	3.28e-06	0.000317	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PSMA2—osteoporosis	3.27e-06	0.000317	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PSMA5—osteoporosis	3.27e-06	0.000317	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MTHFR—osteoporosis	3.03e-06	0.000293	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—POMC—osteoporosis	2.96e-06	0.000286	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ADCY5—osteoporosis	2.81e-06	0.000272	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPX1—osteoporosis	2.8e-06	0.000271	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.65e-06	0.000257	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—POMC—osteoporosis	2.65e-06	0.000257	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MTHFR—osteoporosis	2.59e-06	0.00025	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—POMC—osteoporosis	2.42e-06	0.000234	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADCY5—osteoporosis	2.17e-06	0.00021	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX1—osteoporosis	2.16e-06	0.000209	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—POMC—osteoporosis	2.07e-06	0.0002	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTHFR—osteoporosis	2e-06	0.000193	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—POMC—osteoporosis	1.6e-06	0.000154	CbGpPWpGaD
